Yu, T., Jia, L., Zhu, W., Lu, S., Zhang, Y., Liu, B., . . . He, J. Cbl-b inhibitor NX-1607 activates MAPK/ERK signaling pathway and enhances T-cell activation. BMJ Publishing Group.
Chicago Style (17th ed.) CitationYu, Ting, et al. Cbl-b Inhibitor NX-1607 Activates MAPK/ERK Signaling Pathway and Enhances T-cell Activation. BMJ Publishing Group.
MLA (9th ed.) CitationYu, Ting, et al. Cbl-b Inhibitor NX-1607 Activates MAPK/ERK Signaling Pathway and Enhances T-cell Activation. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.